Malagueira Joao Paulo Falcao 4

What Happened Joao Paulo Falcao Malagueira, a director of Tandem Diabetes Care (TNDM), received a grant of 10,220 restricted stock units (RSUs) on 2026-05-20 and had 8,759 previously granted RSUs vest and convert into shares on 2026-05-21. The reported price for the conversions/transactions is $0, indicating these were non-cash derivative events (award/vesting and conversion), not an open-market cash purchase or sale.

Key Details

• Transactions reported:
  • 2026-05-20: Grant/Award (A) — 10,220 RSUs @ $0.00 (acquired; derivative)
  • 2026-05-21: Exercise/Conversion (M) — 8,759 shares @ $0.00 (acquired; conversion of vested RSUs)
  • 2026-05-21: Exercise/Conversion (M) — 8,759 shares @ $0.00 (disposed; reported as $0)
• Shares owned after the transactions: not specified in the provided filing excerpt.
• Footnotes:
  • F1: Each RSU represents a contingent right to receive one share (or cash in lieu) per the 2023 Long‑Term Incentive Plan.
  • F2: The 10,220 RSUs granted on 2026-05-20 vest on the one‑year anniversary (subject to plan terms).
  • F3: The 8,759 RSUs were originally granted on 2025-05-21 and vested/converted on their one‑year anniversary (2026-05-21).
• Filing timeliness: Report filed 2026-05-22 for transactions on 2026-05-20/21 — appears to be filed promptly (within required reporting window).

Context

• These are derivative/compensation events (RSU grant and vesting/conversion), not open-market buys or sales. Conversion of RSUs into shares is routine compensation‑related activity.
• The matching disposal entry reported at $0 is recorded in the Form 4 but the filing does not specify sale proceeds or the reason for the disposal (e.g., transfer, net settlement, tax withholding); no cash sale value is shown.